Bimuno TRAVELAID Prebiotic Supplements for Travellers Diarrhoea

Bimuno TravelAid

Information for Healthcare Professionals: Bimuno TRAVELAID is specially formulated with the specific needs of holidaymakers and business travelers in mind.


The Clinical Challenge 

UK travellers account for around 23.7 million trips per annum to countries linked with Travellers’ Diarrhoea (TD)1 and the percentage of UK travellers experiencing TD is reported at 30% to 50%2

Symptoms include cramps, nausea, bloating in addition to diarrhoea, which as well as being distressing, can have a financial ‘cost’, eating into precious holiday or business time. 

Moreover, in approximately 15% of TD cases travellers experience vomiting, and up to 10% have diarrhoea accompanied by fever or bloody stools, or both3

More about Bimuno® TRAVELAID 

Bimuno® TRAVELAID is specially formulated with the specific needs of holidaymakers and business travellers in mind. It has a unique dual action in providing nutritional support for the gut microflora of those travelling abroad6. 

The Scientific Evidence 

Supporting gut health of holidaymakers:

• Significant differences vs palcebo in gut health maintenance of holidaymakers6

Prevention of Pathogenic G.I. bacteria colonisation: 

• Bimuno strongly inhibited the attachment and colonisation of G.I. pathogens ~ enteropathogenic Escherichia coli4and Salmonella Typhimurium4,5. These pathogens are linked to most of the confirmed cases of Travellers’ Diarrhoea. 

Who can benefit from Bimuno® TRAVELAID? 

It is ideal for those seeking to help maintain their gut healh when travelling abroad on holiday, on business or sporting events and those who are proactive about their gut travel health.

Recommending Bimuno® TRAVELAID

Bimuno® TRAVELAID is classed as a food supplement and does not have any of the warnings and contra-indications associated with medicinal products.  It is not a medicinal product and is not intended to treat or prevent medical conditions or their symptoms.

Although no adverse effects have been reported, it should be noted that Bimuno® TRAVELAID contains small amounts of lactose (from milk). 

The product contains 30 chewable pastilles and the active ingredient is galacto-oligosaccharides equivalent to a daily dose of 2.76g. It is free from artificial colours, flavours and preservatives and is gluten free. The lactose content is 0.71g* per daily dose. Per daily dose it contains 26 kcal, 3.1g of sugar and 0.0g of fat. 

It is suitable for children aged 6 years and over and for adults. 

The dosage is three pastilles per day. For best results the three pastilles should be taken after breakfast; take one immediately after the other.

Bimuno® TRAVELAID should be taken daily for seven days before travel and then daily for the duration of the holiday or business trip. 

1. Office of Nat Stats: MQ6 Overseas Travel & Tourism Q4 2009, Table 26.
2. Travellers’ Diarrhoea.
4. Tzortzis et al. J Nutr 2005;135:1726-1731.
5. Searle LEJ et al. Journal of Medical Microbiology 2009;58:37-48.
6. Drakoularakou A et al. European Journal of Clinical Nutrition 2010;64:146-152. 



* Lactose doses of less than 12g per day are likely to be tolerated by most of the population of lactose deficient adults. EFSA Journal (2007) 565,1-6 and EFSA Journal 1010;8(9):1777.


This section is an information and educational resource for healthcare professionals, scientists, researchers and journalists. It is not intended for consumers. If you wish to purchase Bimuno please click here

Back to the top